Genomics-based non-invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women-Reference-Cited by-同舟云学术

Genomics-based non-invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women

Published:2017-11-10 Issue:11 Volume:2017 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Badeau Mylène¹,Lindsay Carmen¹,Blais Jonatan²³,Nshimyumukiza Leon⁴,Takwoingi Yemisi⁵,Langlois Sylvie⁶,Légaré France¹,Giguère Yves⁷⁸,Turgeon Alexis F⁹¹⁰,Witteman William¹,Rousseau François⁸¹⁰

Affiliation:

1. CHU de Québec - Université Laval; Population Health and Optimal Health Practices Research Axis; 45 Rue Leclerc Québec City QC Canada G1L 3L5

2. CHAU-Hôtel-Dieu de Lévis; Department of Medical Biology; 143 Rue Wolfe Lévis QC Canada G6V 3Z1

3. Faculty of Medicine, Université Laval; Department of Molecular Biology, Medical Biochemistry and Pathology; Quebec City Quebec Canada

4. University of Alberta; School of Public Health; 8303 112 Street Edmonton Alberta Canada T6G 2T4

5. University of Birmingham; Institute of Applied Health Research; Edgbaston Birmingham UK B15 2TT

6. University of British Columbia; Department of Medical Genetics, Faculty of Medicine; C234, 4500 Oak Street Vancouver BC Canada V6H 3N1

7. CHU de Québec - Université Laval; Reproductive, Mother and Child Health Research Axis; 10, rue de l'Espinay, A2-226 Québec City QC Canada G1L 3L5

8. Faculty of Medicine, Université Laval; Department of Molecular Biology, Medical Biochemistry and Pathology; 10, rue de l'Espinay Québec City Qc Canada G1L 3L5

9. CHU de Québec - Université Laval, Université Laval; Department of Anesthesiology and Critical Care Medicine, Division of Critical Care Medicine, and Population Health and Optimal Health Practices Research Unit, CHU de Québec - Université Laval Research Center; 1401, 18eme rue Quebec City QC Canada G1J 1Z4

10. CHU de Québec Research Center, Université Laval; Population Health and Optimal Health Practices Research Axis; 1401, 18eme rue Québec City Québec Canada G1J 1Z4

Publisher

Wiley

Subject

Pharmacology (medical)

Reference473 articles.

1. Non-invasive prenatal testing for trisomy 21 based on analysis of cell-free fetal DNA circulating in the maternal plasma;Alberti;Prenatal Diagnosis,2015

2. NCT01118507 Trisomy of chromosome 21 diagnosis by high output sequencing clinicaltrials.gov/show/NCT01118507

3. Chromosome-selective sequencing of maternal plasma cell-free DNA for first-trimester detection of trisomy 21 and trisomy 18;Ashoor;American Journal of Obstetrics and Gynecology,2012

4. Trisomy 13 detection in the first trimester of pregnancy using a chromosome-selective cell-free DNA analysis method;Ashoor;Ultrasound in Obstetrics & Gynecology,2013

5. Cell-free DNA analysis in maternal plasma in cases of fetal abnormalities detected on ultrasound examination;Benachi;Obstetrics and Gynecology,2015

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Applications of Fetal Cell‐Free DNA: State of the Science;Journal of Midwifery & Women's Health;2024-07-25

2. Diagnostic accuracy of ultrasound screening for fetal structural abnormalities during the first and second trimester of pregnancy in low-risk and unselected populations;Cochrane Database of Systematic Reviews;2024-05-09

3. Clinical outcomes of screen-positive genome-wide cfDNA cases for trisomy 20: results from the global expanded NIPT Consortium;Molecular Cytogenetics;2024-04-16

4. Performance of noninvasive prenatal screening for fetal sex chromosome aneuploidies in a cohort of 116,862 pregnancies;Expert Review of Molecular Diagnostics;2024-03-25

5. Economic cost of patients with trisomy 13, 18, and 21 in a tertiary hospital in Thailand;PLOS ONE;2023-11-16